Jeffrey Teuteberg
Cardiologist
Associate Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Bio:
Dr. Teuteberg is board certified in Cardiology and Heart Failure and Transplantation. He is currently the Section Chief of Heart Failure, Cardiac Transplantation, and Mechanical Circulatory Support. He sees patients both in the clinic and in the hospital with advanced heart failure and who have received cardiac transplantation or mechanical circulatory support.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He will serve as President of the International Society of Heart and Lung Transplantation in 2018.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He will serve as President of the International Society of Heart and Lung Transplantation in 2018.
Practice Areas
Professional Education
- Board Certification: Advanced Heart Failure and Transplant Cardiology, American Board of Internal Medicine (2010)
- Board Certification: Cardiovascular Disease, American Board of Internal Medicine (2004)
- Fellowship: Brigham and Women's Hospital Heart Transplant (2004) MA
- Fellowship, University of Chicago, Cardiovascular Medicine (2003)
- Residency, University of Chicago, Internal Medicine (1999)
- Medical Education: Pritzker School of Medicine University of Chicago Registrar (1996) IL
Administrative Appointments
- Section Chief, Heart Failure, Cardiac Transplantation, Mechanical Circulatory Support, Cardiovascular Medicine (2017 - Present)
Publications
-
Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial
Pham, M. X., Deng, M. C., Kfoury, A. G., Teuteberg, J. J., Starling, R. C., & Valantine, H. (2007). Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(8), 808–14. -
Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation
Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., Deng, M. C., Cappola, T. P., … Valantine, H. A. (2010). Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 362(20), 1890–1900. -
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Costanzo, M. R., Dipchand, A., Starling, R., Anderson, A., Chan, M., Desai, S., … Vanhaecke, J. (2010). The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(8), 914–56. -
Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients.
Deng, M. C., Elashoff, B., Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., … Valantine, H. A. (2014). Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients. Transplantation, 97(6), 708–14.
-
Gene expression profiling to study racial differences after heart transplantation
Khush, K. K., Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Deng, M. C., Kao, A., … Valantine, H. A. (2015). Gene expression profiling to study racial differences after heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 34(7), 970–77.
-
Prognosis of Right Ventricular Failure in Patients With Left Ventricular Assist Device Based on Decision Tree With SMOTE
Wang, Y., Simon, M., Bonde, P., Harris, B. U., Teuteberg, J. J., Kormos, R. L., & Antaki, J. F. (2012). Prognosis of Right Ventricular Failure in Patients With Left Ventricular Assist Device Based on Decision Tree With SMOTE. IEEE TRANSACTIONS ON INFORMATION TECHNOLOGY IN BIOMEDICINE, 16(3), 383–90.
-
Decision tree for adjuvant right ventricular support in patients receiving a left ventricular assist device
Wang, Y., Simon, M. A., Bonde, P., Harris, B. U., Teuteberg, J. J., Kormos, R. L., & Antaki, J. F. (2012). Decision tree for adjuvant right ventricular support in patients receiving a left ventricular assist device. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 31(2), 140–49.
-
Biventricular assist device utilization for patients with morbid congestive heart failure - A justifiable strategy
Tsukui, H., Teuteberg, J. J., Murali, S., McNamara, D. M., Buchanan, J. R., Winowich, S., … Kormos, R. L. (2005). Biventricular assist device utilization for patients with morbid congestive heart failure - A justifiable strategy. CIRCULATION, 112(9), I65–I72.
-
-
RIGHT VENTRICULAR LOAD ADAPTABILITY IN PATIENTS UNDERGOING CONTINUOUS-FLOW LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION
Amsallem, M., Aymami, M., Hiesinger, W., Zeigler, S., Moneghetti, K., Marques, M., … Haddad, F. (2018). RIGHT VENTRICULAR LOAD ADAPTABILITY IN PATIENTS UNDERGOING CONTINUOUS-FLOW LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71(11), 1624.
-
Accepting hepatitis C virus infected donor hearts for transplantation: Multi-step consent, unrealized opportunity, and the Stanford experience.
Moayedi, Y., Gulamhusein, A. F., Ross, H. J., Teuteberg, J. J., & Khush, K. K. (2018). Accepting hepatitis C virus infected donor hearts for transplantation: Multi-step consent, unrealized opportunity, and the Stanford experience. Clinical Transplantation, e13308.
-
New Horizons on the 50th Anniversary of Heart Transplantation in Canada: "Where There Is Death, There Is Hope"
Moayedi, Y., Alhussein, M., Posada, J. G. D., Kozuszko, S., Khush, K. K., Teuteberg, J. J., … Ross, H. J. (2018). New Horizons on the 50th Anniversary of Heart Transplantation in Canada: "Where There Is Death, There Is Hope". CANADIAN JOURNAL OF CARDIOLOGY, 34(6), 694–95.
-
-
-
-
-
-
Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients.
Moayedi, Y., Foroutan, F., Miller, R. J., Fan, C. P. S., Posada, J. G., Alhussein, M., … Teuteberg, J. J. (2018). Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation.
-
-
-
-
-
-
-
Safety and Efficacy of PCSK9 Inhibitors After Heart Transplantation.
Moayedi, Y., Kozuszko, S., Knowles, J. W., Chih, S., Oro, G., Lee, R., … Khush, K. K. (2019). Safety and Efficacy of PCSK9 Inhibitors After Heart Transplantation. The Canadian Journal of Cardiology, 35(1).
-
-
-
-
-
Infectious complications after heart transplantation in patients screened with gene expression profiling.
Moayedi, Y., Gomez, C. A., Fan, C. P., Miller, R. J., Bunce, P. E., Tremblay-Gravel, M., … Teuteberg, J. J. (2019). Infectious complications after heart transplantation in patients screened with gene expression profiling. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Outcomes in patients undergoing cardiac retransplantation: A propensity matched cohort analysis of the UNOS Registry.
Miller, R. J., Clarke, B. A., Howlett, J. G., Khush, K. K., Teuteberg, J. J., & Haddad, F. (2019). Outcomes in patients undergoing cardiac retransplantation: A propensity matched cohort analysis of the UNOS Registry. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation.
-
-
-
-
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.